Chronic-Dose Safety and Efficacy Study of Albuterol Inhaler in Pediatric Asthmatics
- Study Title
- A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
- Teva Identifier
- ABS-AS-303
- ClinicalTrials.gov Identifier
- NCT02126839
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol MDPI | Drug: Placebo | Drug: ProAir HFA inhaler
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- 05/01/2014 - 02/01/2015
- Phase
- Phase 3
